I

Injective Foundation

Layer-2 DEX for decentralized derivatives

Product Designer - Injective Labs

Full-Time
No salary listed
Mid
Remote in USA
RemoteRemote within North/South America or Europe time zones.
Product & Experience DesignProduct Design

About the job

Requirements
  • At least 3 years of experience in a user interface/user experience design role.
  • Excellent Figma skills.
  • Experience building consumer-facing mobile and web products.
  • Experience developing wireframes and prototypes.
  • Experience developing and maintaining design systems.
  • Ability to communicate effectively and push back when necessary on a cross-functional team.
  • Proven ability to lead product design discovery and manage the end-to-end design process from initial concept through final delivery.
  • Strong information design experience and a solid foundation in user experience design heuristics.
  • Deep knowledge and applied experience in graphic design, including layout, typography, and color.
  • A portfolio demonstrating the quality and care of the candidate's design work.
  • Availability to work within North/South America or Europe time zones.
Responsibilities
  • Lead design projects across the entire product lifecycle and multiple product launches.
  • Strengthen the design practice, influence product strategy, and improve product execution and quality.
  • Partner closely with engineering, product, and business teams to develop elegant and practical solutions to design challenges.
  • Use user feedback to influence product-design strategy and solutions.
  • Develop and maintain product design systems.
  • Rapidly produce multiple concepts and prototypes, applying pixel-perfect detail when appropriate and low-fidelity sketches and prototypes when appropriate.
Desired Qualifications
  • Experience at a consumer fintech company.
  • Adobe Creative Suite, including Photoshop, Illustrator, and After Effects.
  • Previous experience working in the crypto space.
  • Previous experience working at an exchange, including a centralized exchange or decentralized exchange.

About the company

Injective Foundation operates a layer-2 decentralized exchange (DEX) protocol that enables unlimited decentralized finance markets focused on derivatives, futures, perpetuals, and spot trading. It achieves this by running a cross-chain, layer-2 platform that conducts secure, instant, and borderless trades, with fees earned from transactions and staking services. The platform targets traders ranging from novices to professionals by offering a user-friendly interface plus advanced trading features. Compared to competitors, Injective distinguishes itself with its scalable, cross-chain L2 design that supports a wide range of markets directly on the blockchain, reducing reliance on centralized intermediaries. Its goal is to unlock the full potential of decentralized derivatives and DeFi trading by providing secure, high-throughput, and borderless access to diverse markets.

Company Size

51-200

Company Stage

Late Stage VC

Total Funding

$52.6M

Headquarters

New York City, New York

Founded

2018

Get referred to Injective Foundation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • October 2026 Stockdrop expands tokenized stock marketing around Nvidia, AMC, and Meta.
  • September 2026 buyback rounds burned over 7.2 million INJ, tightening supply.
  • Korea Blockchain Week on September 29, 2026 showcased POSCO and LG CNS pilots.

What critics are saying

  • August 31, 2026 exploit halted block production for 3 hours 42 minutes.
  • The binary-options vulnerability exposed core protocol risk, not just one application.
  • CypherOS lacks audits and architecture details; institutions avoid unproven privacy stacks.

What makes Injective Foundation unique

  • Injective launched Sunrise on August 28, 2026, bringing native INJ to Solana.
  • Injective became the SEC-registered transfer agent on August 19, 2026.
  • Meridian on September 24, 2026 added compliance-ready tokenization and MultiVM perpetual markets.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Unlimited Paid Time Off
  • Home Office Stipend
  • Flexible Work Hours
  • Performance Bonus

Company News

Bitcoin News
Oct 20th, 2026
Injective and BDACS target tokenized asset settlement with won stablecoin KRW1.

Injective and BDACS target tokenized asset settlement with won stablecoin KRW1. Injective and BDACS are partnering to deploy KRW1, a Korean won-backed stablecoin, for tokenized asset settlement as Seoul shapes its local currency stablecoin rules. The intersection of local currency stablecoins and real-world asset tokenization is moving from theory to live infrastructure in East Asia, and South Korea is shaping up to be one of its most consequential proving grounds. Injective and BDACS have announced a partnership to deploy KRW1 - a Korean won-backed stablecoin - as a settlement layer for tokenized assets, a move that arrives precisely as Seoul is drafting the regulatory scaffolding to make such instruments legally viable. The timing is not incidental. South Korea's financial regulators have been signaling for some time that local currency stablecoins will form a distinct, regulated category under the country's evolving digital asset framework. Unlike the dollar-centric stablecoin ecosystem that has dominated global decentralized finance (DeFi) and institutional tokenization, a won-denominated instrument would allow Korean market participants to transact in native currency without the foreign exchange friction that comes with using USDT or USDC as settlement rails. That seemingly technical distinction carries enormous practical weight for institutional actors operating under Korean accounting, tax, and hedging rules. KRW1 is designed specifically to address that gap. By pairing a won-pegged stablecoin with Injective's blockchain infrastructure - a layer-1 network built around financial applications, derivatives, and orderbook-style exchanges - the partnership is positioning itself to handle the settlement layer for tokenized bonds, equities, and other real-world assets (RWAs) denominated in Korean won. BDACS, which focuses on digital asset custody and structuring for institutional clients, brings the compliance and custody architecture that any serious RWA platform requires on the back end. Why settlement currency matters more than it looks. Most coverage of asset tokenization focuses on the representation layer - turning a bond or a piece of real estate into a blockchain token. Far less attention goes to the settlement layer, which is where transactions actually clear and counterparties exchange value. If that settlement layer requires converting into a foreign-currency stablecoin and back again, institutions absorb currency risk, conversion costs, and potential regulatory complications around holding foreign-denominated instruments. A won-native settlement token eliminates those friction points in a single stroke, making tokenized Korean assets genuinely practical for domestic institutional buyers rather than theoretically appealing but operationally cumbersome. This is the strategic logic underpinning the Injective-BDACS collaboration. It is not primarily a DeFi play - it is an institutional market-structure play, one that treats the stablecoin not as a speculative asset but as functional financial plumbing. The choice of Injective as the underlying chain reflects a deliberate preference for a network purpose-built for financial instruments, rather than a general-purpose smart contract platform retrofitted for institutional use. Seoul's regulatory window is opening. The regulatory context deserves as much attention as the technical one. South Korea has historically been one of the world's most active retail crypto markets, but its institutional and tokenization frameworks have lagged behind the trading volumes its citizens generate. That is now changing. Korean authorities are actively constructing rules specifically for local currency stablecoins - a category that sits differently under Korean law than foreign-issued instruments like Tether's Tether (USDT) or Circle's USD Coin (USDC). For Injective and BDACS, moving early inside that regulatory process is a calculated positioning move. Projects that engage with regulators during framework development tend to have structural advantages when final rules land - their architecture already reflects the direction of regulatory travel, while latecomers must retrofit compliance after the fact. If South Korea's stablecoin rules ultimately carve out a licensed path for won-backed instruments operating on blockchain settlement networks, KRW1 could be among the first to benefit from that clarity rather than scrambling to meet requirements designed without their input. The broader RWA calculus. The Injective-BDACS announcement is one node in a much larger global conversation about which chains, stablecoins, and custodians will own the infrastructure layer of tokenized finance. In Asia alone, multiple jurisdictions - Japan, Hong Kong, Singapore - are racing to establish themselves as hubs where traditional financial assets can migrate onto blockchain rails under credible legal frameworks. South Korea, with its deep capital markets, tech-literate institutional base, and high retail crypto adoption, is a logical candidate to join that group. What the KRW1 initiative signals, beyond its immediate scope, is that the tokenization race is increasingly granular. It is no longer sufficient to build a generic tokenization platform and point it at global markets. The winning infrastructure plays are those that solve jurisdiction-specific problems - local currency settlement, local regulatory compliance, local custody standards - with precision. The partnership between Injective and BDACS is an early, concrete example of that more nuanced approach finding its footing in one of Asia's most significant digital asset markets. Sarah williams. Web3 and tokenomics researcher. Analyzes token models, DAO governance, and decentralized infrastructure. § Comments Open discussion no account needed

Crypto Briefing
Oct 20th, 2026
Injective partners with BDACS to bring KRW1 stablecoin to its RWA ecosystem

Injective partners with BDACS to bring KRW1 stablecoin to its RWA ecosystem. The Korean won-backed token, held in escrow at Woori Bank, will be available for trading and settlement on Injective's network an hour ago Injective official brand logo (injective.com brand kit) Sponsored: Vera - AI-powered prediction market intelligence, built for serious analysts Explore Vera Injective has signed a strategic partnership with BDACS, a South Korean digital asset custodian, to integrate KRW1 into its network. KRW1 is a stablecoin backed by the Korean won. The deal, announced on October 20, 2026, will enable KRW1 trading and settlement inside Injective's real-world asset ecosystem. What the partnership actually does. Under the partnership, KRW1 can be traded and used for settlement on Injective. The integration targets Injective's real-world asset, or RWA, ecosystem. RWAs are traditional financial instruments represented as tokens on a blockchain. The aim is to link conventional fiat rails with blockchain infrastructure designed for institutional users. How KRW1 is backed. KRW1 is fully backed by Korean won. That collateral sits in escrow at Woori Bank, with 100% of it held there. Verification happens in real time through banking APIs. Instead of waiting for a quarterly attestation, the reserve can be checked against live bank data. KRW1's initial proof-of-concept wrapped up on September 18, 2025, and ran on the Avalanche network. That trial was conducted alongside Woori Bank. The news moving money, markets, and the world - before your day starts. Daily. Free. Join 34,000+ readers across crypto, finance, and policy. Since then, the token has spread across several blockchains, including Ethereum and BNB Chain. Cross-chain movement relies on LayerZero's OFT standard. Injective is the latest stop on a growing itinerary. The numbers so far. As of October 20, 2026, KRW1's on-chain supply stood at approximately 13.67 million. Earlier reports put total holdings at about 142 million KRW equivalent. Background: why a won stablecoin matters. A won-denominated option removes foreign exchange exposure for Korean institutions settling on-chain. BDACS, as a custodian, sits in the middle of that bridge, providing reserve transparency that traditional finance players typically demand. KRW1 is also still awaiting further regulatory approval. What this means. For Injective, the partnership adds a non-dollar settlement currency to its RWA push. For BDACS, Injective represents another distribution channel. Multi-chain reach through LayerZero means liquidity does not have to be rebuilt from scratch on every network. With an on-chain supply of approximately 13.67 million, adoption is clearly at an early stage. Growth will depend on whether trading venues and RWA issuers actually choose to price and settle in won. If KRW1's on-chain supply climbs meaningfully from its current level after landing on Injective, that would signal real demand for won-based settlement. Disclosure: This article was edited by Kaye Quema. For more information on how Cryptobriefing create and review content, see its Editorial Policy.

TronWeekly
Oct 16th, 2026
Injective launches new USDC CCTP route as INJ price outlook draws attention.

Injective launches new USDC CCTP route as INJ price outlook draws attention. Injective has introduced a new USDC Cross-Chain Transfer Protocol route through LI.FI and Jumper, expanding stablecoin access across its ecosystem. The network has also surpassed 3 billion cumulative transactions, while analyst Crypto Patel maintains long-term INJ targets of $80 and $200 following a reported 242% rally from his accumulation zone. Injective has expanded USDC access through a new cross-chain integration, strengthening its ecosystem and stablecoin connectivity. Growing network activity supports its development, while analyst Crypto Patel maintains a bullish INJ price outlook following a trendline breakout. Future performance depends on adoption, market momentum, and sustained support. Table of contents. Injective expands USDC access via cross-chain integration. Injective has launched a new Cross-Chain Transfer Protocol (CCTP) route for USDC, allowing users to onboard the stablecoin through LI.FI and Jumper. The integration supports Injective's efforts to expand stablecoin accessibility and connect its financial applications with liquidity across multiple blockchain networks. The project also aims to establish Injective as a canonical stablecoin standard across more than 20 blockchains. Broader access to USDC could help users move dollar-pegged liquidity into Injective's ecosystem for trading, decentralized finance, and other on-chain financial activities. Network activity surpasses 3 billion transactions. Injective reported more than 3 billion cumulative transactions, with over 46 million recorded during the previous 30 days. The milestone highlights the network's reported transaction activity as it expands its infrastructure and cross-chain capabilities. However, transaction counts alone do not establish the number of active users or the economic value processed by the network. Continued growth in active addresses, stablecoin liquidity, and application usage would provide additional evidence of ecosystem adoption. The new USDC route could support that expansion by making it easier to transfer native stablecoins onto Injective. Its longer-term impact will depend on whether users and applications adopt the integration and generate sustained demand for on-chain liquidity. INJ price structure turns bullish after trendline breakout. Crypto Patel reported that the INJ price is trading near $9.36 after rising approximately 242% from the $2.60-$2.70 accumulation zone he shared on February 28, 2026. The analyst identified a break above a long-term descending trendline and highlighted $5.908 as a key level for maintaining the bullish market structure. Holding above that threshold would support his technical thesis, while a sustained breakdown below it could weaken the setup. The $9.36 price reflects the analyst's reported figure, not a verified live market quote. Current price action and trading volume would need to be checked to assess whether the bullish momentum remains intact. Crypto Patel maintains $80 and $200 INJ targets. Crypto Patel continues to identify $80 and $200 as his long-term targets for the INJ price. His outlook follows the reported trendline breakout and recovery from the accumulation zone. These targets remain speculative and would require substantial additional price appreciation. The strength of the broader crypto market, sustained buying pressure, and INJ's ability to hold important support levels will influence whether the rally can continue. The new USDC integration and transaction milestone add fundamental context to the analyst's outlook, but neither development guarantees that INJ will reach those levels. After a sharp rally, traders may also take profits, potentially increasing short-term volatility. What comes next for Injective? Injective's next important milestones include adoption of the CCTP route, growth in stablecoin liquidity, and sustained network activity. Wider use of USDC could strengthen the ecosystem's appeal to traders and developers seeking cross-chain financial infrastructure. For INJ, the key question is whether the token can preserve its bullish structure above the analyst's identified $5.908 level. Continued network growth and stronger liquidity could support market confidence, while weakening momentum or broader market pressure could challenge the recovery. Injective's expanding USDC connectivity and reported 3 billion transaction milestone provide a stronger ecosystem narrative. However, sustained adoption and market performance will matter more than transaction counts or long-term price targets alone. This article contains market analysis and price predictions. These are not guarantees. Crypto markets are volatile. Always DYOR. Not financial advice. Usman Zafar Usman Zafar is a News Desk writer at Tronweekly with over five years of experience in cryptocurrency and blockchain journalism. He covers Bitcoin, Ethereum, DeFi, crypto laws and regulation, market activity, Layer 2 scaling solutions, and blockchain-based innovations, focusing on fast-moving developments and official industry updates. Usman previously wrote for BTCread and follows strict verification and editing practices to ensure accurate, timely, and responsible crypto news for a global audience.

Upgate
Oct 14th, 2026
Injective markets heavily tied to tokenized assets.

Injective markets heavily tied to tokenized assets. Oct 14, 2026 Reading time: 3 min Injective blockchain expands tokenized asset offerings, achieves SEC transfer agent status. Injective, a Layer-1 blockchain designed for financial applications, has significantly expanded its offerings of tokenized real-world assets (RWAs), with nearly half of its markets now providing exposure to these instruments. As of mid-October 2026, the platform hosts 135 active RWA perpetual markets, encompassing a diverse range of asset classes. A perpetual is a type of futures contract that does not have an expiration date, allowing traders to speculate on an asset's price movements without directly owning the underlying asset. Equities lead the charge in RWA markets. Equities form the largest segment of Injective's RWA market, featuring over 111 stock markets. The platform also offers markets for foreign exchange, commodities, and indices. Notably, Injective has introduced markets for pre-IPO assets, including private companies such as SpaceX and OpenAI, which are not yet traded on public exchanges. Since early 2025, Injective's RWA perpetual markets have collectively generated over $5.3 billion in trading volume. In August 2026, monthly activity reached approximately $210 million. Landmark SEC registration paves way for on-chain securities. On October 12, 2026, Injective made history by becoming the first Layer-1 blockchain to be registered as an SEC transfer agent. This registration enables Injective to maintain compliant on-chain records of securities ownership. The distinction is crucial: while a perpetual contract tracks a price, a tokenized security registered through a transfer agent is intended to represent legal ownership. This regulatory milestone followed the publication of a new whitepaper on October 7, 2026, which outlined three key features: native RWA issuance, role-based permissions, and iAssets, a suite of derivatives products. Role-based permissions empower issuers to control asset access and transfers, a requirement for regulated securities. Tokenization efforts and trader appeal. On-chain tokenization efforts are gaining momentum, with over $1 billion worth of mortgage records already processed. Pineapple Financial, a participant on the platform, aims to tokenize more than $10 billion in assets. For traders, Injective offers a unified on-chain venue for accessing equities, foreign exchange, commodities, and pre-IPO companies. However, perpetuals tracking pre-IPO companies present unique challenges, as the absence of public price discovery can complicate valuation and lead to volatility and wide spreads in thinly traded markets. Future outlook for Injective's RWA ecosystem. Several key developments will be worth monitoring in the coming months. These include whether monthly RWA trading volume can surpass the approximately $210 million recorded in August, whether Injective's transfer agent status will spur native securities issuance on the blockchain, and if Pineapple Financial will progress towards its ambitious $10 billion tokenization target.

BlockTelegraph
Oct 11th, 2026
Bitroot brings the Parallel AI Blockchain to TOKEN2049 Singapore.

Bitroot brings the Parallel AI Blockchain to TOKEN2049 Singapore. Bitroot, the parallel EVM Layer 1 blockchain built for AI, marked its presence at TOKEN2049 Singapore 2026 with a keynote on the main stage, an exhibition booth at Marina Bay Sands, and two co-hosted side events during TOKEN2049 week. Held on 7 and 8 October, TOKEN2049 Singapore drew more than 25,000 attendees, making it one of the largest gatherings of founders, investors and builders in the global Web3 industry. Main-Stage Keynote: The Parallel AI Blockchain for the Machine Economy On the TOKEN2049 main stage, Juan Ortega, CEO delivered Bitroot's keynote, "The Parallel AI Blockchain for the Machine Economy." The talk set out why AI agents, autonomous applications and machine-to-machine payments need a base layer that can execute transactions in parallel, verify AI workloads onchain and settle at the speed machines operate. "AI agents are becoming economic actors in their own right, and they need infrastructure that keeps up with them," said Juan Ortega, CEO of Bitroot. "TOKEN2049 is where the industry decides what gets built next. Our message this week was simple: the machine economy needs a chain designed for it from day one, and Bitroot is that chain." Exhibition Booth at Marina Bay Sands Across both days of the main event, the Bitroot team met developers, investors, exchanges and ecosystem partners at its booth inside the TOKEN2049 exhibition hall, with live walkthroughs of the Bitroot testnet, its official DEX and bridge, and the developer tools available to teams building AI-native applications. Two Co-Hosted Side Events During TOKEN2049 Week Bitroot extended its presence beyond the main venue by co-hosting two side events with leading industry partners: Web3 x AI In Action (6 October, Tahir Building, Robinson Road): an official TOKEN2049 side event hosted by Microsoft, Injective Foundation and Web3Labs, with Bitroot as co-host. The evening brought together infrastructure builders, AI practitioners, institutional investors and policymakers for a keynote and two panels on where onchain finance and AI meet, from autonomous agents executing onchain to AI-native financial applications and the regulatory frameworks shaping them across Asia. Ultra Connect Singapore (7 October, Marina Bay Sands): a business networking evening co-hosted with Web3Labs as part of the Ultra Web3 Festival, attended by more than 1,000 investors, financial institutions, funds, family offices, founders and corporate decision-makers. "Singapore was a milestone week for Bitroot," said Jerry Yu, Head of Growth at Bitroot, who led the team's TOKEN2049 programme. "Between the main stage, the booth and two side events with partners like Microsoft, Injective and Web3Labs, we put Bitroot in front of the builders and capital that will shape the machine economy. We are already following up on the conversations that started here." Bitroot's TOKEN2049 appearance follows its platinum sponsorship of GWDC 2026 in Seoul the week before, as part of a sustained push into the Asian and global markets in the second half of 2026. About Bitroot Bitroot is a parallel EVM Layer 1 blockchain built for AI and the machine economy. Using Pipeline BFT consensus with BLS signature aggregation, Bitroot is designed for high-throughput parallel execution and fast finality, giving AI agents and AI-native applications a base layer that can keep pace with them. The Bitroot testnet is live with more than 300,000 addresses, an official DEX and bridge, and an ecosystem of more than 90 partners. Media Contact Head of Growth, Bitroot [email protected]